CPHRF News and Press, Companhia Siderurgica Paulista Nova Cosipa From 05/12/23

2023-05-12 12:33:05 ET Cipher Pharmaceuticals Inc. (CPHRF) Q1 2023 Earnings Conference Call May 12, 2023 8:30 am ET Corporate Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial Officer Conference Call Participants Dou...

2023-05-11 17:53:13 ET Cipher Pharmaceuticals press release ( OTCPK:CPHRF ): Q1 GAAP EPS of $0.10 beats by $0.02 . Revenue of $4.9M (-9.3% Y/Y) misses by $0.64M . For further details see: Cipher Pharmaceuticals GAAP EPS of $0.10 beats by $0.02, revenue of $4....

2023-03-17 11:48:04 ET Cipher Pharmaceuticals Inc. (CPHRF) Q4 2022 Earnings Conference Call March 17, 2023 08:30 ET Company Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial Officer Conference Call Participants Doug ...

Cipher Pharmaceuticals Inc. (CPHRF) Q3 2022 Earnings Conference Call November 11, 2022 08:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial Officer David Miller - Director, Finance Conference Call Part...

Cipher Pharmaceuticals press release ( OTCPK:CPHRF ): Q3 GAAP EPS of $0.11. Revenue of $4.8M (+6.7% Y/Y). For further details see: Cipher Pharmaceuticals GAAP EPS of $0.11, revenue of $4.8M

Cipher Pharmaceuticals Inc. (CPHRF) Q2 2022 Earnings Conference Call August 12, 2022, 08:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Scott Langille - Chief Financial Officer David Miller - Director, Finance Conference Call Par...

Cipher Pharmaceuticals press release ( OTCPK:CPHRF ): Q2 GAAP EPS of $0.08. Revenue of $5.6M (-8.2% Y/Y) misses by $0.8M . For further details see: Cipher Pharmaceuticals GAAP EPS of $0.08, revenue of $5.6M misses by $0.8M

Cipher Pharmaceuticals press release (OTCPK:CPHRF): Q1 GAAP EPS of C$0.08. Revenue of C$5.4M (flat Y/Y). For further details see: Cipher Pharmaceuticals GAAP EPS of C$0.08, revenue of C$5.4M

Cipher Pharmaceuticals Inc. (CPHRF) Q4 2021 Earnings Conference Call March 18, 2022, 8:30 AM ET Company Participants Craig Mull – Interim Chief Executive Officer Scott Langille – Chief Financial Officer David Miller – Director, Finance Conference Call Participants Andre U...

Cipher Pharmaceuticals press release (OTCPK:CPHRF): Q4 GAAP EPS of C$0.11. Revenue of C$5.9M (-3.3% Y/Y). For further details see: Cipher Pharmaceuticals GAAP EPS of C$0.11, revenue of C$5.9M